IUC26665-90

Abstract Code: IUC26665-90   Global inequalities in prostate cancer incidence and mortality: an ecological analysis Hosseini 1, Y. Vaez-Gharamaleki 1, A. Motamedi 1 (1) Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz –...

IUC26663-88

Abstract Code: IUC26663-88   Real-world ARASENS triplet therapy in high-volume mHSPC: a single-centre cohort M.P. Juan Gonzalez 1, C. Martinez Martinez 1, A.J. Montalban Valverde 1, P.A. Barranzuela Decoll 1, Y. El Farh Boumajdil 1, E.J. Soria Hernandez 1, B....

IUC26662-87

Abstract Code: IUC26662-87   Ultra-low PSA as a real-world indicator of androgen receptor pathway inhibitors (ARPI) treatment response in metastatic prostate cancer Ghigeanu 1, I. Bogatu 2, M.A. Barbu 3 (1) Bucharest Institute of Oncology – Romania, (2)...

IUC26661-86

Abstract Code: IUC26661-86   Real-world outcomes in patients with Metastatic Hormone-Sensitive Prostate Cancer treated with androgen deprivation therapy and Apalutamide – A single centre study Marchon 1, S. Brown 1, K. Swaminathan 1, S. Adeyemi 1, G. Kapur...

IUC26659-93

Abstract Code: IUC26659-93   Transdermal Estradiol as an Alternative to LHRH Agonists in Prostate Cancer Management Khanna 1, S. Debra 1, D. Sethi 1, M. Abdel-Missih 1 (1) The University of Buckingham Medical School, Crewe – United Kingdom  ...

IUC26655-89

Abstract Code: IUC26655-89   Pretreatment Hemoglobin-Albumin-Lymphocyte-Platelet Score, Dosimetry, and Acute Toxicity After Definitive Prostate Radiotherapy: Interim Real-World Evidence Depboylu 1, T. Bahceci 2, H. Onder 3, Y. Yalcin 4 (1) Aydin Adnan Menderes...
error: Content is protected !!